Teva announces new strategic focus in the Japanese market
Japan Business Venture shifts focus to specialty assets and a portfolio of select generics that meet patients’ medical needs Remains positioned to address unmet patient needs in core therapeutic areas Will divest majority of current non-differentiated generics portfolio, as well as local